PROMs between FBHE and HE groups across study timepoints
| Baseline | 2 weeks | 4 weeks | 6 weeks | |||||||||
| FBHE (n=9) | HE (n=10) | P value | FBHE (n=9) | HE (n=10) | P value | FBHE (n=9) | HE (n=10) | P value | FBHE (n=9) | HE (n=10) | P value | |
| 100 mm VAS: maximum pain in the last week | 54.8±16.3 | 41.1±15.3 | 0.07 | 42.2±21.2 | 47.5±13.4 | 0.51 | 34.5±21.9* | 36.2±17.1* | 0.85 | 19.3±20.5*† | 31.3±27.4*† | 0.28 |
| 100 mm VAS: pain at rest in the last week | 7.9±6.1 | 4.1±3.9 | 0.11 | 8.5±11.6 | 6.1±5.0 | 0.56 | 3.5±4.4 | 4.5±7.6 | 0.72 | 1.7±3.8† | 3.4±4.1† | 0.35 |
| 100 mm VAS: pain during typical run in the last week | 33.4±18.8 | 31.4±12.3 | 0.78 | 23.7±16.4 | 25.6±12.7 | 0.78 | 20.3±15.4* | 21.7±12.1* | 0.82 | 12.5±15.2* | 20.5±21.8* | 0.35 |
| 100 mm VAS: pain following typical run in the last week | 24.5±16.8 | 24.7±13.3 | 0.98 | 13.0±8.1 | 21.1±15.4 | 0.16 | 7.4±8.0* | 20.2±19.8* | 0.07 | 4.9±6.7*† | 11.8±11.7*† | 0.12 |
| EILP-Br (%) | 76.5±8.3 | 74.0±13.1 | 0.62 | – | – | – | 89.2±8.6* | 81.5±15.0* | 0.17 | 94.6±5.3* | 80.0±10.2* | <0.001‡ |
| LEFS (%) | 89.3±9.0 | 85.4±14.6 | 0.48 | – | – | – | 96.5±2.6* | 92.6±5.6* | 0.06 | 98.3±2.1* | 91.6±4.3* | <0.001‡ |
| Wisconsin RRI (%) | 58.3±7.6 | 47.2±16.9 | 0.08 | 76.9±10.1 | 63.1±14.5 | 0.02‡ | 85.2±12.0*† | 71.6±14.0*† | 0.03‡ | 91.4±7.7*† | 74.6±8.5*† | <0.001‡ |
| GROC (−7 to 7) | – | – | – | 3±2 | 3±2 | 0.81 | 6±1† | 5±2† | 0.09 | 6±1† | 3±2† | .004‡ |
*Statistically significant compared with baseline at p≤0.05.
†Statistically significant compared with 2 weeks at p≤0.05.
‡Statistically significant differences between groups at p≤0.05.
EILP-Br, Exercise-Induced Leg Pain Questionnaire, British Version; FBHE, contact time gait-training feedback with home exercise; HE, home exercise; LEFS, Lower Extremity Functional Scale; PROM, patient-reported outcome measure; RRI, Running Injury and Recovery Index; VAS, Visual Analogue Scale.